
Bostonsight publishes groundbreaking study highlighting PROSE® lens utilization for drug delivery
NEEDHAM, MA, UNITED STATES, November 21, 2024 /EINPresswire.com/ -- BostonSight® announced it has published a groundbreaking study: “Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: …